Accentuating the caveat emptor perspective with critical commentary on financial disclosure. I adopt a skeptical persona and look for chinks in the teflon coating of financial disclosure. My job is to identify financial warts. Perhaps a Black Swan. Disclosure: I do not hold positions in stocks mentioned for three trading days before or after blog post.
Thursday, June 22, 2006
Gene Logic Guidance Stumble
Gene Logic Inc. (NASDAQ:GLGC) announced today that revenue for its Genomics Division will be significantly lower than previously anticipated for both the second quarter and for the full year 2006. Without really getting into any substantive details the company has also yanked their guidance. To season the debacle they indicate Gene Logic's Senior Vice President and General Manager, Genomics, has resigned for personal reasons and to pursue other career opportunities. The Company already has in place interim leadership for its Genomics Division. You may have to hunt about for the names. Basically we have no real information on the problem. The company further adds that an executive has fallen on his sword. Problems of this magnitude are never the fault of one individual. Will they solve problems or just get into the blame game.